Effects of Steroids and Curcumin on Prevention of Laryngeal Stenosis Secondary to Trauma

Document Type : Original


1 Department of Otorhinolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.

3 Stem cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.


The aim of this study was to compare the preventive effects of corticosteroids and curcumin on subglottic stenosis in an animal model.
 Materials and Methods:
Twenty-one male German Shepherd dogs were used for this study. After standardized trauma to the subglottic area, the dogs were divided into three groups. Group A received curcumin (450 mg/ day) for 15 days; Group B received beclomethasone (2 puffs/day, 50 µg/dose) for 15 days; Group C received saline spray only. At 6 weeks after the injury, the larynx specimens were examined histopathologically to assess epithelialization, inflammation, and fibrosis.
Complete epithelial covering of the steroid-treated group was significantly less than that of the control group. Despite inflammation and fibrosis, there was no significant difference between the steroid and control groups. In the curcumin-treated group, there was no significant difference between the groups.
Topically applied steroid decreases epithelialization after induced subglottic injury. It is recommended that further studies be conducted in order to investigate the effects of the two drugs on airway stenosis prevention.


Main Subjects

1. Ertugrul EE, Cekin IE, Cincik H, Dogra S, Gungor A. Effectiveness of topically applied halofuginone in management of subglottic stenosis in rats.Otolaryngol Head Neck Surg 2009; 140:720–3.
2. Talas DU, Nayci A, Atis S, Comelekoglu U, Polat A, Bagdatoglu C, et al. The effects of corticosteroids and vitamin A on the healing of tracheal anastomoses. Int J Pediatr Otorhinolaryngol 2003;67:265–71.
3. Cincik H, Gungor A, Cakmak A, Omeroglu A, Poyrazoglu E, Yildirim S, et al. The effects of mitomycin C and 5- fluorouracil / triamcinolone on fibrosis/ scar tissue formation secondary to subglottic trauma (experimental study). Am J Otolaryngol 2005; 26: 45–50.
4. Krishna P, Rosen CA, Branski RC, Wells A, Hebda PA. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar. Otolaryngol Head Neck Surg 2006; 135(6):937–45.
5. Barnes PJ. Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am 2005;25: 451–68.
6. Cato Ac, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996;18: 371–8.
7.Chrousos G. Adenocorticosteroids and adenocortical antagonist. In: Katzung B, Masters S, Trevor A. Basic and Clinical Pharmacology.12th edition, United States: McGraw-Hill; 2012:697–713.
8.Skigen AL, Bedrock RD, Stopperich PS. Correction of the depressed, retracted, post-tracheostomy scar. Plast Reconstr Surg 1999;103: 1703-5.
9. Kim CS, Buchmiller TL, Fonkalsrud EW, Phillips JD. The effects of anabolic steroids on ameliorating the adverse effects of chronic corticosteroids on intestinal anastomotic healing in rabbits. Surg Gynecol Obstet 1993; 176: 73–9.
10. Healy GB. An experimental model for the endoscopic correction of subglottic stenosis with clinical applications. Laryngoscope 1982;92:1103-15.
11. Talas DU, Nayci A, Atis S, Polat A, Comelekoglu U, Bagdatoglu C, et al. The effects of corticosteroids on the healing of tracheal anastomoses in a rat model. Pharmacol Res 2002; 45:299–304.
12. Wicke C, Halliday B, Allen D, Roche NS, Scheuenstuhl H, Spencer MM, et al. Effects of steroids and retinoids on wound healing. Arch Surg 2000; 135:1265–70.
13. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4: 807–18.
14. Aggarwal BB, Kumar A, Bharti AC. Anticancer Potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23(1A): 363– 98.
15. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010; 103: 1545–57.
16. Singh S, Aggarwal BB. Activation of transcription factor NF-Kappa B is suppressed by curumin (diferuloylmethane). J Biol Chem 1995; 270: 24995–5000.
17. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, Baldwin AS. A nucleosomal function for Ikappa B Kinase-alpha in NF-kappa B-dependent gene expression. Nature 2003; 423:659–63.
18. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloyl methane) down-regulates cigarette smoke-induced NF-kappa B activation through inhibition of l-kappa alpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003; 24:1269–79.
19. Rafiee P, Nelson VM, Manley S, Wellner M, Floer M, Binion DG, et al. Effect of curcumin on acidic PH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET 1A): role of PKC, MAPKs and NF-Kappa B. Am J Physiol Gastrointest Liver Physiol 2009; 296: G388–98.
20. Ingrams DR, Sukin SW, Ashton P, Valtonen HJ, Pankratov MM, Shapshay SM. Does slow–release 5-fluorouracil and triamcinolone reduce subglottic stenosis? Otolaryngol Head Neck Surg1998; 118:174–7.
21. Yoon YH, Rha KS, Koo BS, Park JY, Kim YM, Park YH. The preventive effect of halofuginone on posterior glottic stenosis in a rabbit model. Otolaryngol Head Neck Surg 2008; 139:94–9.
22. Roh JL. Prevention of posterior glottic stenosis by mitomycin C. Ann Otol Rhinol Laryngol 2005; 114:558;62.